Differential susceptibility of allogeneic targets to indirect CD4 immunity generates split tolerance

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4603-4612

  Chan, William F N ^a   Razavy, Haide ^a   Anderson, Colin C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; FEMALE; FETUS; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE MIGRATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SKIN ALLOGRAFT; SKIN TRANSPLANTATION; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE MUTANT; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ALLOANTIGEN; HY ANTIGEN;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHIMERA; FEMALE; H-Y ANTIGEN; IMMUNITY, INNATE; ISLETS OF LANGERHANS TRANSPLANTATION; ISOANTIGENS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; MODELS, ANIMAL; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE;

EID: 58149308841     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4603     Document Type: Article

References (68)

1. Zijlstra, M., H. Auchincloss, Jr., J. M. Loring, C. M. Chase, P. S. Russell, and R. Jaenisch. 1992. Skin graft rejection by β 2-microglobulin-deficient mice. J. Exp. Med. 175: 885-893.
2. -- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J. Immunol. 156: 4114-4119.
3. Gill, R. G., A. S. Rosenberg, K. J. Lafferty, and A. Singer. 1989. Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts. J. Immunol. 143: 2176-2178.
4. + T cells are both necessary and sufficient for islet xenograft rejection. Transplant. Proc. 26: 1203.
5. Auchincloss, H., Jr., R. Lee, S. Shea, J. S. Markowitz, M. J. Grusby, and L. H. Glimcher. 1993. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90: 3373-3377. (Pubitemid 23111368)
6. Kupfer, T. M., M. L. Crawford, K. Pham, and R. G. Gill. 2005. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo. J. Immunol. 175: 2309-2316.
7. Braun, M. Y., I. Grandjean, P. Feunou, L. Duban, R. Kiss, M. Goldman, and O. Lantz. 2001. Acute rejection in the absence of cognate recognition of allograft by T cells. J. Immunol. 166: 4879-4883. (Pubitemid 32280696)
8. Perez-Diez, A., N. T. Joncker, K. Choi, W. F. Chan, C. C. Anderson, O. Lantz, and P. Matzinger. 2007. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 109: 5346-5354. (Pubitemid 46890556)
9. Elkins, W. L., and R. D. Guttmann. 1968. Pathogenesis of a local graft versus host reaction: immunogenicity of circulating host leukocytes. Science 159: 1250-1251.
10. Snell, G. D. 1957. The homograft reaction. Annu. Rev. Microbiol. 11: 439-458.
11. Benichou, G., A. Valujskikh, and P. S. Heeger. 1999. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 162: 352-358. (Pubitemid 29018940)
12. Benichou, G., P. A. Takizawa, C. A. Olson, M. McMillan, and E. E. Sercarz. 1992. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175: 305-308.
13. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
14. Millrain, M., P. Chandler, F. Dazzi, D. Scott, E. Simpson, and P. J. Dyson. 2001. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis. J. Immunol. 167: 3756-3764. (Pubitemid 32910821)
15. Millrain, M., D. Scott, C. Addey, H. Dewchand, P. Ellis, I. Ehrmann, M. Mitchell, P. Burgoyne, E. Simpson, and J. Dyson. 2005. Identification of the immunodominant HY H2-D(k) epitope and evaluation of the role of direct and indirect antigen presentation in HY responses. J. Immunol. 175: 7209-7217. (Pubitemid 41713415)
16. + T cells through the indirect presentation pathway in vivo. J. Immunol. 171: 6510-6518.
17. + T cells or B cells. J. Immunol. 161: 1868-1874.
18. Chen, Y., Y. Demir, A. Valujskikh, and P. S. Heeger. 2004. Antigen location contributes to the pathological features of a transplanted heart graft. Am. J. Pathol. 164: 1407-1415. (Pubitemid 38387806)
19. + indirect response. Xenotransplantation 5: 93-98.
20. Makhlouf, L., A. Yamada, T. Ito, R. Abdi, M. J. Ansari, C. Q. Khuong, H. J. Winn, H. Auchincloss, Jr., and M. H. Sayegh. 2003. Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice. J. Am. Soc. Nephrol. 14: 2168-2175. (Pubitemid 36909926)
21. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 88: 527-531.
22. Yamada, A., A. Chandraker, T. M. Laufer, A. J. Gerth, M. H. Sayegh, and H. Auchincloss, Jr. 2001. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J. Immunol. 167: 5522-5526.
23. Cao, X., E. W. Shores, J. Hu-Li, M. R. Anver, B. L. Kelsall, S. M. Russell, J. Drago, M. Noguchi, A. Grinberg, E. T. Bloom, et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2: 223-238.
24. + T cell survival but not for antigen proliferation. Nat. Immunol. 1: 54-58.
25. Chan, W. F., A. Perez-Diez, H. Razavy, and C. C. Anderson. 2007. The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits. Biol. Direct. 2: 10.
26. Nanji, S. A., W. W. Hancock, B. Luo, C. D. Schur, R. L. Pawlick, L. F. Zhu, C. C. Anderson, and A. M. Shapiro. 2006. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes 55: 27-33.
27. Goldman, K. P., C. S. Park, M. Kim, P. Matzinger, and C. C. Anderson. 2005. Thymic cortical epithelium induces self tolerance. Eur. J. Immunol. 35: 709-717.
28. Anderson, C. C., and P. Matzinger. 2001. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat. Med. 7: 80-87.
29. McKenzie, I. F., G. M. Morgan, M. S. Sandrin, M. M. Michaelides, R. W. Melvold, and H. I. Kohn. 1979. B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J. Exp. Med. 150: 1323-1338.
30. Bastien, E., A. Holter, T. Garrick, W. Elkins, and F. Stuart. 1970. Role of passenger leukocytes in the rejection of renal allografts. Surg. Forum 21: 256-258.
31. Stuart, F. P., T. Garrick, A. Holter, A. Lynch, and E. Bastien. 1971. Delayed rejection of renal allografts in the rat and dog by reduction of passenger leukocytes. Surgery 70: 128-134.
32. Lafferty, K. J., M. A. Cooley, J. Woolnough, and K. Z. Walker. 1975. Thyroid allograft immunogenicity is reduced after a period in organ culture. Science 188: 259-261.
33. Lacy, P. E., J. M. Davie, and E. H. Finke. 1979. Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science 204: 312-313.
34. 1 kidneys into secondary AS recipients. J. Exp. Med. 150: 455-464.
35. Faustman, D. L., R. M. Steinman, H. M. Gebel, V. Hauptfeld, J. M. Davie, and P. E. Lacy. 1984. Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc. Natl. Acad. Sci. USA 81: 3864-3868.
36. Coulombe, M., and R. G. Gill. 1994. Tolerance induction to cultured islet allografts: I. Characterization of the tolerant state. Transplantation 57: 1195-1200. (Pubitemid 24139641)
37. Talmage, D. W., G. Dart, J. Radovich, and K. J. Lafferty. 1976. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 191: 385-388.
38. Lechler, R. I., and J. R. Batchelor. 1982. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155: 31-41.
39. Kieper, W. C., and S. C. Jameson. 1999. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc. Natl. Acad. Sci. USA 96: 13306-13311.
40. Cabatingan, M. S., M. R. Schmidt, R. Sen, and R. T. Woodland. 2002. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J. Immunol. 169: 6795-6805.
41. Ernst, B., D. S. Lee, J. M. Chang, J. Sprent, and C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11: 173-181. (Pubitemid 29428810)
42. Goldrath, A. W., L. Y. Bogatzki, and M. J. Bevan. 2000. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192: 557-564.
43. Heeger, P. S. 2003. T-cell allorecognition and transplant rejection: a summary and update. Am. J. Transplant. 3: 525-533.
44. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61: 246-257.
45. Miller, R. G., and H. Derry. 1979. A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J. Immunol. 122: 1502-1509.
46. Fink, P. J., R. P. Shimonkevitz, and M. J. Bevan. 1988. Veto cells. Annu. Rev. Immunol. 6: 115-137.
47. Helft, J., A. Jacquet, N. Joncker, I. Grandjean, G. Dorothee, A. Kissenpfennig, B. Malissen, P. Matzinger, and O. Lantz. 2008. Antigen specific T-T interactions regulate CD4 T cell expansion. Blood 112: 1249-1258.
48. + T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? Blood 101: 2704-2710.
49. Jones, N. D., S. E. Turvey, A. Van Maurik, M. Hara, C. I. Kingsley, C. H. Smith, A. L. Mellor, P. J. Morris, and K. J. Wood. 2001. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J. Immunol. 166: 2824-2830.
50. He, C., S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger. 2004. Effects of T cell frequency and graft size on transplant outcome in mice. J. Immunol. 172: 240-247. (Pubitemid 38020477)
51. Fiori, P., G. Ristori, A. Cacciani, C. Buttinelli, M. Falcone, S. Di Giovanni, C. Montesperelli, C. Pozzilli, and M. Salvetti. 1997. Down-regulation of cell-surface CD4 co-receptor expression and modulation of experimental allergic encephalomyelitis. Int. Immunol. 9: 541-545. (Pubitemid 27168487)
52. Schonrich, G., U. Kalinke, F. Momburg, M. Malissen, A. M. Schmitt-Verhulst, B. Malissen, G. J. Hammerling, and B. Arnold. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65: 293-304. (Pubitemid 121006059)
53. Schonrich, G., F. Momburg, M. Malissen, A. M. Schmitt-Verhulst, B. Malissen, G. J. Hammerling, and B. Arnold. 1992. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int. Immunol. 4: 581-590.
54. + T cell tolerance and linked suppression. J. Immunol. 163: 4805-4810.
55. Derks, R. A., E. Jankowska-Gan, Q. Xu, and W. J. Burlingham. 2007. Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1. J. Immunol. 179: 3443-3451.
56. + T regulatory cells: relevance to mechanism of heart allograft tolerance. J. Immunol. 179: 6749-6761.
57. Brent, L., and T. H. Courtenay. 1962. On the induction of split tolerance. In Mechanisms of Immunological Tolerance. M. Hasek, A. Lengerova, and M. Vojtiskova, eds. Czechoslovak Academy of Sciences, Prague, p. 113.
58. Emery, D., and P. McCullagh. 1980. Immunological reactivity between chimeric cattle twins. I. Homograft reaction. Transplantation 29: 4-9. (Pubitemid 10072437)
59. Ildstad, S. T., S. M. Wren, J. A. Bluestone, S. A. Barbieri, and D. H. Sachs. 1985. Characterization of mixed allogeneic chimeras: immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 162: 231-244.
60. Metzler, B., P. Gfeller, M. Bigaud, J. Li, G. Wieczorek, C. Heusser, P. Lake, and A. Katopodis. 2004. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection. J. Immunol. 173: 7025-7036. (Pubitemid 39541092)
61. Luo, B., W. F. Chan, A. M. Shapiro, and C. C. Anderson. 2007. Non-myeloablative mixed chimerism approaches and tolerance, a split decision. Eur. J. Immunol. 37: 1233-1242. (Pubitemid 46925308)
62. Silverman, M. S., and P. H. Chin. 1962. Differences in the rejection of skin transplants and blood cells of donor marrow origin by radiation-induced chimeras. Ann. NY Acad. Sci. 99: 542-549.
63. Boyse, E. A., E. A. Carswell, M. P. Scheid, and L. J. Old. 1973. Tolerance of Sk-incompatible skin grafts. Nature 244: 441-442.
64. Boyse, E. A., and L. J. Old. 1968. Loss of skin allograft tolerance by chimeras. Transplantation 6: 619.
65. Steinmuller, D., and J. S. Lofgreen. 1974. Differential survival of skin and heart allografts in radiation chimaeras provides further evidence for Sk histocompatibility antigen. Nature 248: 796-797.
66. Chan, W. F., H. Razavy, B. Luo, A. M. Shapiro, and C. C. Anderson. 2008. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras. J. Immunol. 180: 5177-5186.
67. + T cells. Nature 376: 181-184.
68. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87: 319-329.